Evidence map›Paper›PMID 32006482›Full record

ArticleAmerican journal of ophthalmology2020

Ocular Complications in School-Age Children and Adolescents after Allogeneic Bone Marrow Transplantation.

Mary Ellen Hoehn, Robert Vestal, Julie Calderwood, Edwin Gannon, Brittany Cook, Richard Rochester, Christine Hartford, Brandon Triplett, Anusha Sunkara, Guolian Kang and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Late effects of the treatment of childhood cancer.World journal of clinical cases · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mary Ellen HoehnDepartment of Surgery, St. Jude Children's Hospital, Memphis, Tennessee; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee College of Medicine, Memphis, Tennessee. Electronic address: mhoehn@uthsc.edu.
Robert VestalDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee College of Medicine, Memphis, Tennessee.
Julie CalderwoodEye Center Surgeons and Associates, Huntsville, Alabama.
Edwin GannonDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee College of Medicine, Memphis, Tennessee.
Brittany CookDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee College of Medicine, Memphis, Tennessee.
Richard RochesterDepartment of Bone Marrow Transplant, St. Jude Children's Hospital, Memphis, Tennessee.
Christine HartfordDepartment of Bone Marrow Transplant, St. Jude Children's Hospital, Memphis, Tennessee.
Brandon TriplettDepartment of Bone Marrow Transplant, St. Jude Children's Hospital, Memphis, Tennessee.
Anusha SunkaraDepartment of Biostatistics, St. Jude Children's Hospital, Memphis, Tennessee.
Guolian KangDepartment of Biostatistics, St. Jude Children's Hospital, Memphis, Tennessee.
R Christopher WaltonDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee College of Medicine, Memphis, Tennessee.
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

purposeTo determine the ocular complications in school-age children and adolescents surviving at least 1 year following allogeneic bone marrow transplantation.

designRetrospective cohort study.

methodsIn this institutional study, 162 patients (7-18 years old) met our inclusion criteria with a mean age of 13.4 years at bone marrow transplantation. Follow-up ranged from 13 months to 12 years (mean 4 years; median 3.2 years). Patient charts were screened for cataract formation, dry eye, and other anterior and posterior segment diseases.

resultsCataract formation was noted in 57 patients. Univariate analysis showed that fractionated total body irradiation, race, and use of cytarabine significantly increased the incidence of cataract formation (P < 0.05). Multivariate analysis of significant variables showed that total body irradiation was a risk factor for cataract formation. Of the 57 patients (97 eyes) who developed cataracts after bone marrow transplantation, 4 patients (6 eyes) required cataract surgery. After surgery, all patients had visual acuities of 20/20 to 20/25. Of the 162 patients, 51 developed dry eyes. Univariate analysis showed that age at transplantation; steroid use, chronic graft-versus-host disease; use of fludarabine, melphalan, and thiotepa; and receiving no pre-transplantation conditioning regimen prior to bone marrow transplant significantly increased the risk of dry eye syndrome (P < 0.05). In multivariate analysis, chronic graft-versus-host disease was a significant risk factor for dry eye syndrome.

conclusionsDue to the high incidence of cataract formation and dry eye disease in this population, this study proposes these patients be screened using examinations by a pediatric or general ophthalmologist at least every year.

Indexed as

AdolescentAnterior Eye SegmentBone Marrow TransplantationCataractChildDry Eye SyndromesEye DiseasesFemaleFollow-Up StudiesGraft vs Host DiseaseHematologic DiseasesHumansMalePosterior Eye SegmentRetrospective StudiesRisk Factors

Identifiers

PMID32006482
PMCPMC7419076
OpenAlexW3011611296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.